Central Laboratory and Vaccination Centre, Stiftung Juliusspital, Würzburg, Germany;
Department of Medical Sciences, Section of Infectious Diseases, Uppsala University, Akademiska Sjukhuset, Uppsala, Sweden;
Pfizer Inc., Collegeville, USA;
Pfizer Pharma GmbH, Berlin, Germany;
Pfizer Vaccine Research, Pfizer, Pearl River, USA;
13-Valent; Pneumococcal; Conjugate; Vaccine; 23-Valent; Pneumococcal; Polysaccharide; Vaccine; Streptococcus; pneumoniae; Reactogenicity; Safety;